cinacalcet has been researched along with Death, Sudden, Cardiac in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chertow, GM; Edenberg, HJ; Foroud, TM; Liu, S; Moe, SM; Robinson-Cohen, C; Schwantes-An, TH; Stedman, M; Vatta, M; Wetherill, L; Zheng, N | 1 |
| Chertow, GM; Decker, BS; Edenberg, HJ; Foroud, TM; Liu, S; Moe, SM; Schwantes-An, TH; Stedman, M; Vatta, M; Wetherill, L | 1 |
| Abdalla, S; Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC | 1 |
1 trial(s) available for cinacalcet and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
Topics: Atherosclerosis; Calcimimetic Agents; Cinacalcet; Death, Sudden, Cardiac; Double-Blind Method; Female; Heart Failure; Humans; Hyperparathyroidism, Secondary; Intention to Treat Analysis; Kidney Failure, Chronic; Male; Naphthalenes; Renal Dialysis; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2014 |
2 other study(ies) available for cinacalcet and Death, Sudden, Cardiac
| Article | Year |
|---|---|
APOL1 G3 Variant Is Associated with Cardiovascular Mortality and Sudden Cardiac Death in Patients Receiving Maintenance Hemodialysis of European Ancestry.
Topics: Apolipoprotein L1; Cinacalcet; Death, Sudden, Cardiac; Heart Failure; Humans; Renal Dialysis | 2022 |
Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.
Topics: Adult; Aged; Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Death, Sudden, Cardiac; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Genetic Predisposition to Disease; Glucuronidase; Heart Failure; Humans; Hyperparathyroidism, Secondary; Kaplan-Meier Estimate; Klotho Proteins; Male; Middle Aged; Multicenter Studies as Topic; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Receptor, Fibroblast Growth Factor, Type 4; Renal Dialysis | 2019 |